Cargando…

Effectiveness of remdesivir in hospitalized nonsevere patients with COVID-19 in Japan: A large observational study using the COVID-19 Registry Japan

OBJECTIVES: To evaluate the effectiveness of remdesivir in the early stage of nonsevere COVID-19. Although several randomized controlled trials have compared the effectiveness of remdesivir with that of a placebo, there is limited evidence regarding its effect in the early stage of nonsevere COVID-1...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tsuzuki, Shinya, Hayakawa, Kayoko, Uemura, Yukari, Shinozaki, Tomohiro, Matsunaga, Nobuaki, Terada, Mari, Suzuki, Setsuko, Asai, Yusuke, Kitajima, Koji, Saito, Sho, Yamada, Gen, Shibata, Taro, Kondo, Masashi, Izumi, Kazuo, Hojo, Masayuki, Mizoue, Tetsuya, Yokota, Kazuhisa, Nakamura-Uchiyama, Fukumi, Saito, Fumitake, Sugiura, Wataru, Ohmagari, Norio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8857764/ https://www.ncbi.nlm.nih.gov/pubmed/35192953 http://dx.doi.org/10.1016/j.ijid.2022.02.039

Ejemplares similares

Effectiveness of Favipiravir on Nonsevere, Early-Stage COVID-19 in Japan: A Large Observational Study Using the COVID-19 Registry Japan
por: Tsuzuki, Shinya, et al.
Publicado: (2022)

Clinical characteristics of the first three waves of hospitalised patients with COVID-19 in Japan prior to the widespread use of vaccination: a nationwide observational study
por: Matsunaga, Nobuaki, et al.
Publicado: (2022)

Predicting respiratory failure for COVID-19 patients in Japan: a simple clinical score for evaluating the need for hospitalisation
por: Yamada, Gen, et al.
Publicado: (2021)

Clinical Epidemiology of Hospitalized Patients With Coronavirus Disease 2019 (COVID-19) in Japan: Report of the COVID-19 Registry Japan
por: Matsunaga, Nobuaki, et al.
Publicado: (2020)

Predictors of silent hypoxia in hospitalized patients with COVID-19 in Japan
por: Hayakawa, Kayoko, et al.
Publicado: (2022)

First and second COVID-19 waves in Japan: A comparison of disease severity and characteristics
por: Saito, Sho, et al.
Publicado: (2021)

Risk factors for severity on admission and the disease progression during hospitalisation in a large cohort of patients with COVID-19 in Japan
por: Terada, Mari, et al.
Publicado: (2021)

908. Evaluation of Blood Culture Submission Rates in Japan
por: Tajima, Taichi, et al.
Publicado: (2020)

Decline in Antimicrobial Consumption and Stagnation in Reducing Disease Burden due to Antimicrobial Resistance in Japan
por: Tsuzuki, Shinya, et al.
Publicado: (2023)

The influence of pre-admission antiplatelet and anticoagulation therapy on the illness severity in hospitalized patients with COVID-19 in Japan
por: Togano, Tomiteru, et al.
Publicado: (2021)

Comparison of the clinical characteristics and outcomes of COVID-19 in children before and after the emergence of Delta variant of concern in Japan
por: Shoji, Kensuke, et al.
Publicado: (2022)

Evaluation of the efficacy of anticoagulation therapy in reducing mortality in a nationwide cohort of hospitalized patients with coronavirus disease in Japan
por: Hara, Hisao, et al.
Publicado: (2021)

Clinical efficacy of remdesivir for COVID-19 in children: A propensity-score-matched analysis
por: Shoji, Kensuke, et al.
Publicado: (2023)

Neutralising activity and antibody titre in 10 patients with breakthrough infections of the SARS-CoV-2 Omicron variant in Japan
por: Okumura, Nobumasa, et al.
Publicado: (2022)

2032. First National Survey of Antimicrobial and Antifungal Stewardship in Japan
por: Moriyama, Yuki, et al.
Publicado: (2019)

Improved penicillin susceptibility of Streptococcus pneumoniae and increased penicillin consumption in Japan, 2013–18
por: Tsuzuki, Shinya, et al.
Publicado: (2020)

233. Improved Penicillin Susceptibility of Streptococcus pneumoniae and Increased Penicillin Consumption in Japan, 2013–18
por: Tsuzuki, Shinya, et al.
Publicado: (2020)

Comparative effectiveness of tocilizumab vs standard care in patients with severe COVID-19-related pneumonia: a retrospective cohort study utilizing registry data as a synthetic control
por: Uemura, Yukari, et al.
Publicado: (2023)

Nationwide cross-sectional study of antimicrobial stewardship and antifungal stewardship programs in inpatient settings in Japan
por: Moriyama , Yuki, et al.
Publicado: (2021)

Renin-angiotensin system blocker and the COVID-19 aggravation in patients with hypertension, diabetes, renal failure, Cerebro-cardiovascular disease, or pulmonary disease: Report by the COVID-19 Registry Japan
por: Yoshihara, Fumiki, et al.
Publicado: (2022)

Longitudinal trends of and factors associated with inappropriate antibiotic prescribing for non-bacterial acute respiratory tract infection in Japan: A retrospective claims database study, 2012–2017
por: Kimura, Yuki, et al.
Publicado: (2019)

1193. Comparison of the Clinical Outcomes of Patients With IMP-Type Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae and Carbapenem-Sensitive Enterobacteriaceae in Japan
por: Saito, Sho, et al.
Publicado: (2018)

External validation and update of prediction models for unfavorable outcomes in hospitalized patients with COVID-19 in Japan
por: Yamada, Gen, et al.
Publicado: (2021)

1182. Risk Factors for the Acquisition of IMP-Type Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae in Japan: A Matched Case–control Study
por: Saito, Sho, et al.
Publicado: (2018)

Characteristics of hospitalized COVID-19 patients with other respiratory pathogens identified by rapid diagnostic test
por: Suzuki, Michiyo, et al.
Publicado: (2023)

2473. Trends in Methicillin Resistance Rate of Staphylococcus aureus among Medical Facilities Participating in Japan Nosocomial Infections Surveillance (JANIS)
por: Suzuki, Yuka, et al.
Publicado: (2019)

Risk factors associated with asymptomatic hypoxemia among COVID-19 patients: a retrospective study using the nationwide Japanese registry, COVIREGI-JP
por: Akiyama, Yutaro, et al.
Publicado: (2022)

Temporal trends in microbial detection during the COVID-19 pandemic: Analysis of the Japan surveillance for Infection Prevention and Healthcare Epidemiology (J-SIPHE) database
por: Endo, Akira, et al.
Publicado: (2023)

Clinical characteristics and prognosis of immunosuppressed inpatients with COVID-19 in Japan
por: Nomoto, Hidetoshi, et al.
Publicado: (2022)

The effect of casirivimab with imdevimab on disease progression in nonsevere COVID‐19 patients in a single hospital in Japan
por: Komagamine, Junpei, et al.
Publicado: (2021)

7. Clinical outcomes and epidemiological characteristics of bacteremia in the older population of Japan
por: Nakamura, Keiji, et al.
Publicado: (2021)

We Should Pay More Attention to Sex Differences to Predict the Risk of Severe COVID-19: Men Have the Same Risk of Worse Prognosis as Women More Than 10 Years Older
por: Matsushita, Yumi, et al.
Publicado: (2023)

National database study of trends in bacteraemia aetiology among children and adults in Japan: a longitudinal observational study
por: Kusama, Yoshiki, et al.
Publicado: (2021)

Predictive model of risk factors of High Flow Nasal Cannula using machine learning in COVID-19
por: Matsunaga, Nobuaki, et al.
Publicado: (2022)

Cost of inappropriate antimicrobial use for upper respiratory infection in Japan
por: Tsuzuki, Shinya, et al.
Publicado: (2020)

Seroprevalence of antibodies against SARS-CoV-2 in a large national hospital and affiliated facility in Tokyo, Japan
por: Tanaka, Akihito, et al.
Publicado: (2021)

2201. Cost of Antimicrobial Use Against Upper Respiratory Infection in Japan
por: Tsuzuki, Shinya, et al.
Publicado: (2019)

223. Difference in Carbapenem Use by ASP Intervention in Japanese Healthcare Facilities
por: Endo, Mio, et al.
Publicado: (2020)

Awareness survey of so-called Dappou drugs or Kiken drugs (New Psychoactive Substances) among University Students in Japan
por: Fuse-Nagase, Yasuko, et al.
Publicado: (2015)

Treatment with tecovirimat of the first two cases of monkeypox in Japan
por: Inada, Makoto, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0e4u0ekbg3p1l4bttm0r3p8q77